BEST LAWRENCE C 4
4 · HAEMONETICS CORP · Filed Jul 22, 2011
Insider Transaction Report
Form 4
BEST LAWRENCE C
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2011-07-21$68.81/sh+3,559$244,895→ 3,559 totalExercise: $68.81From: 2012-07-21Exp: 2018-07-21→ Common Stock (3,559 underlying) - Award
Common Stock
2011-07-21$0.01/sh+944$9→ 3,145 total
Holdings
- 5,879
Non-Qualified Stock Option (right to buy)
Exercise: $59.44From: 2010-07-30Exp: 2016-07-30→ Common Stock (5,879 underlying) - 4,592
Non-Qualified Stock Option (right to buy)
Exercise: $49.92From: 2008-08-01Exp: 2014-08-01→ Common Stock (4,592 underlying) - 6,000
Non-Qualified Stock Option (right to buy)
Exercise: $52.76From: 2006-05-05Exp: 2013-05-05→ Common Stock (6,000 underlying) - 4,290
Non-Qualified Stock Option (right to buy)
Exercise: $54.48From: 2011-07-29Exp: 2017-07-29→ Common Stock (4,290 underlying) - 5,664
Non-Qualified Stock Option (right to buy)
Exercise: $58.46From: 2009-07-31Exp: 2018-07-31→ Common Stock (5,664 underlying) - 20,000
Non-Qualified Stock Option (right to buy)
Exercise: $20.46From: 2003-08-22Exp: 2013-08-22→ Common Stock (20,000 underlying)
Footnotes (4)
- [F1]Restricted Stock Unit Grant which vest 100% on the first anniversary of the grant date. Grant was made under 2005 Long Term Incentive Compensation Plan.
- [F2]Total includes Restricted Stock Awards and/or Restricted Stock Units that are subject to restrictions until vesting requirements are met. Grant was made under 2005 Long Term Incentive Compensation Plan.
- [F3]Grant to reporting person of right to buy shares of common stock exercisable 100 percent on the first anniversary of the date of grant.
- [F4]Grant to reporting person of right to buy shares of common stock exercisable immediately.